GlassScriptPhysician profile
Leonel Trujillo
NPI 1285073338
$4,024.84
in general payments reported to CMS, 2019-2025
23 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $61.10 · 2021: $1,746 · 2022: $1,506 · 2023: $203 · 2024: $172 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.40 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,478.99 | 2021 | |
| Acessa Health INC. | $1,191.45 | 2022 | |
| Hologic Sales and Service, LLC | $387.83 | 2020-2025 | Acessa Provu System |
| Astellas Pharma US INC | $159.98 | 2024-2025 | |
| Davol INC. | $94.18 | 2024-2025 | Arista Ah Flexitip, Arista |
| Daiichi Sankyo INC. | $91.44 | 2021-2025 | Injectafer |
| Therapeuticsmd, INC. | $64.88 | 2021 | |
| Exeltis, USA INC. | $63.54 | 2025 | Slynd |
| Abbvie INC. | $63.46 | 2023 | Orilissa, Lo Loestrin Fe |
| Conmed Corporation | $54.05 | 2021 | |
| Myovant Sciences INC. | $53.65 | 2021-2022 | |
| Teleflex LLC | $41.70 | 2025 | Quikclot, Weck |
| Baxter Healthcare | $41.02 | 2023-2024 | Perclot, Adept |
| Coopersurgical, INC. | $37.54 | 2022-2025 | Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $29.96 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $29.21 | 2022-2023 | V-Loc 180 |
| Monaghan Medical Corporation | $24.75 | 2023 | Aeroeclipse |
| Organon LLC | $23.66 | 2025 | Nexplanon |
| Smith+Nephew, INC. | $21.22 | 2021 | |
| Ethicon US, LLC | $19.80 | 2022 | |
| Pfizer INC. | $18.10 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $17.60 | 2025 | |
| Merck Sharp & Dohme LLC | $16.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonel Trujillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.